Delivery Order SPE2DB22D2206-SPE2DB24FJF50
Award Date
7/16/24
Potential Completion Date
8/6/24
Potential Value
$3.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML, a pharmaceutical product, with a ceiling value of $3,581.62 and a performance period ending on May 23, 2025. The contract is a firm fixed-price, non-set-aside delivery order. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML. The ceiling value of the contract is $3,756.72, with an ultimate completion date of August 6, 2024. The contract is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, supporting...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The order is for the medical product HYPERRAB 300 UNIT/ML VIALML, with a ceiling value of $3,721.90 and a completion date of August 9, 2024. This is a firm-fixed-price contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) by the DLA and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $6,616.74 and has an ultimate completion date of April 8, 2025. It is for the procurement of HYPERRAB 300 UNIT/ML VIAL 3ML, a medical product. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML, a pharmaceutical product. The contract has a ceiling value of $4,967.66 and a completion date of July 7, 2025. The contract is a Firm Fixed Price, non-set-aside contract, indicating open competition. Amerisourcebergen Drug...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of HYPERRAB 300 UNIT/ML VIALML. The firm-fixed-price contract has a ceiling value of $2,079.06 and an ultimate completion date of July 21, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp is a for-profit organization headquartered in Conshohocken,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,744.80, is for the delivery of HYPERRAB 300 UNIT/ML VIAL 5ML medical supplies. The contract is not set-aside and has an ultimate completion date of June 25, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML, a pharmaceutical product. The contract has a firm fixed price of $10,744.80 and a completion date of June 3, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award, valued at $14,326.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HYPERRAB 300 UNIT/ML VIAL 5ML, a medical product, and has a completion date of March 10, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,954.00, is for the delivery of HYPERRAB 300 UNIT/ML VIAL 5ML, a medical product. The contract has a firm fixed price and is a delivery order type, with a completion date of March 11, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...